Bio Rad Gross Profit vs. Book Value Per Share

BIO Stock  USD 332.91  7.33  2.25%   
Based on the measurements of profitability obtained from Bio Rad's financial statements, Bio Rad Laboratories may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Bio Rad's ability to earn profits and add value for shareholders.
 
Gross Profit  
First Reported
1985-09-30
Previous Quarter
355.7 M
Current Value
355.9 M
Quarterly Volatility
122.8 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Bio Rad's Price To Sales Ratio is very stable compared to the past year. As of the 25th of November 2024, Days Sales Outstanding is likely to grow to 87.31, while Operating Cash Flow Sales Ratio is likely to drop 0.08. At this time, Bio Rad's Operating Income is very stable compared to the past year. As of the 25th of November 2024, Non Operating Income Net Other is likely to grow to about 54.1 M, though Accumulated Other Comprehensive Income is likely to grow to (319.2 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.630.5358
Fairly Up
Pretty Stable
For Bio Rad profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bio Rad to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bio Rad Laboratories utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bio Rad's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bio Rad Laboratories over time as well as its relative position and ranking within its peers.
  

Bio Rad's Revenue Breakdown by Earning Segment

Check out Trending Equities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.412
Earnings Share
(28.06)
Revenue Per Share
90.815
Quarterly Revenue Growth
0.028
Return On Assets
0.0186
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bio Rad Laboratories Book Value Per Share vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bio Rad's current stock value. Our valuation model uses many indicators to compare Bio Rad value to that of its competitors to determine the firm's financial worth.
Bio Rad Laboratories is rated fourth in gross profit category among its peers. It is number one stock in book value per share category among its peers . The ratio of Gross Profit to Book Value Per Share for Bio Rad Laboratories is about  5,864,057 . At this time, Bio Rad's Gross Profit is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio Rad's earnings, one of the primary drivers of an investment's value.

Bio Rad's Earnings Breakdown by Geography

Bio Book Value Per Share vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Bio Rad

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
1.57 B
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Bio Rad

Book Value per Share

 = 

Common Equity

Average Shares

 = 
267.46 X
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.

Bio Book Value Per Share Comparison

Bio Rad is currently under evaluation in book value per share category among its peers.

Bio Rad Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Bio Rad, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bio Rad will eventually generate negative long term returns. The profitability progress is the general direction of Bio Rad's change in net profit over the period of time. It can combine multiple indicators of Bio Rad, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-336 M-319.2 M
Operating Income383.8 M403 M
Income Before Tax-850.1 M-807.6 M
Total Other Income Expense Net-1.2 B-1.2 B
Net Loss-637.3 M-605.5 M
Income Tax Expense-212.8 M-202.1 M
Net Loss-4.2 B-4 B
Net Loss-159.3 M-151.3 M
Non Operating Income Net Other51.5 M54.1 M
Interest Income96.4 M91.6 M
Net Interest Income47.6 M50 M
Change To Netincome4.7 BB
Net Loss(21.82)(20.73)
Income Quality(0.59)(0.56)
Net Income Per E B T 0.75  0.58 

Bio Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bio Rad. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bio Rad position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bio Rad's important profitability drivers and their relationship over time.

Use Bio Rad in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Bio Rad Pair Trading

Bio Rad Laboratories Pair Trading Analysis

The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Bio Rad position

In addition to having Bio Rad in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Military Industrial Thematic Idea Now

Military Industrial
Military Industrial Theme
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
To fully project Bio Rad's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bio Rad Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bio Rad's income statement, its balance sheet, and the statement of cash flows.
Potential Bio Rad investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Bio Rad investors may work on each financial statement separately, they are all related. The changes in Bio Rad's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bio Rad's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.